BLK
BlackRock, Inc.
BLK's fundamentals are mixed, but it looks expensive: trading at 28x earnings, above its usual 22x.
HCMA
HCM III Acquisition Corp.
There isn't enough reported data to score HCMA yet.
BLK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BLK's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BLK.
HCMA Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| N/A | |
| N/A |
HCMA's profitability is currently healthy. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like HCMA.
BLK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 19x | $848 | -30% |
| Fair | 22x | $973 | -20% |
| Expensive | 26x | $1,149 | -5.5% |
| Current | 28x | $1,217 | — |
Historical ranges are pointers, not guarantees.
BLK's PE is in its expensive range at 28x.
HCMA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 63x | $10.04 | -2.9% |
| Current | 63x | $10.34 | — |
| Fair | 96x | $15.30 | +48% |
| Expensive | 184x | $29.47 | +185% |
Historical ranges are pointers, not guarantees.
HCMA has the edge over BLK in the historical PE scenario, which offers more potential upside but is not a forecast.
BLK Forward outlook
There aren't enough analyst estimates for BLK to show an outlook.
HCMA Forward outlook
There aren't enough analyst estimates for HCMA to show an outlook.
BLK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $43.87 | +11% |
| Q2 2026 | $41.73 | -0.4% |
| Q1 2026 | $39.73 | -4.7% |
| Q4 2025 | $35.31 | -17% |
| Q3 2025 | $39.42 | -2.7% |
| Q2 2025 | $41.89 | +4% |
| Q1 2025 | $41.69 | +5.9% |
| Q4 2024 | $42.53 | +16% |
BLK has the edge over HCMA in the latest year-over-year earnings comparison.
HCMA Earnings Per Share
HCMA earned $0.16 per share over the past year, down 71% from the year before.
BLK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7.8B | +19% |
| Q2 2026 | $7.1B | +31% |
| Q1 2026 | $6.7B | +27% |
| Q4 2025 | $7B | +23% |
| Q3 2025 | $6.5B | +25% |
| Q2 2025 | $5.4B | +13% |
| Q1 2025 | $5.3B | +12% |
| Q4 2024 | $5.7B | +23% |
BLK has the edge over HCMA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | 0 points |
| Q2 2026 | 35% | +2.8 points |
| Q1 2026 | 42% | +9.8 points |
| Q4 2025 | 24% | -13 points |
| Q3 2025 | 30% | -8.6 points |
| Q2 2025 | 32% | -5.5 points |
| Q1 2025 | 32% | -3.6 points |
| Q4 2024 | 37% | +2.3 points |
BLK's operating margin was 30% last quarter, about level with the same quarter a year ago, near the bottom of its range since 2019.
HCMA Quarterly Revenue
HCMA's revenue is shrinking: $0 last quarter.
BLK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.6B | +95% |
| Q2 2026 | $1.1B | -12% |
| Q1 2026 | -$1.1B | +$120M |
| Q4 2025 | $2.1B | -15% |
| Q2 2025 | $1.3B | -6.1% |
| Q1 2025 | -$1.2B | -$734M |
| Q4 2024 | $2.5B | +35% |
| Q2 2024 | $1.4B | +47% |
BLK has the stronger cash trend. Its trailing FCF is up 20% versus its history, compared with HCMA at down 141%.
HCMA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2023 | -$447.6K | -$346.2K |
| Q2 2023 | -$340.4K | -$240.2K |
| Q1 2023 | -$255.3K | +$256.1K |
| Q4 2022 | -$177.2K | -$176.2K |
| Q3 2022 | -$101.5K | -$98.2K |
| Q2 2022 | -$100.1K | -$100.1K |
| Q1 2022 | -$511.4K | -$503.9K |
HCMA's free cash flow was −$2M over the past year, against −$874,338 the year before. Free cash flow isn't a meaningful measure for financial services companies like HCMA.
BLK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -148K shares |
| 1 year | -0.4% | -677K shares |
| 3 years | +9.3% | +14M shares |
| 5 years | +6.2% | +9.6M shares |
| Available history | +4.4% | +7M shares |
BLK has the edge over HCMA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2025 | $396M |
| Q1 2025 | $657M |
| Q4 2024 | $386M |
| Q2 2024 | $519M |
| Q1 2024 | $634M |
| Q4 2023 | $384M |
| Q3 2023 | $396M |
| Q2 2023 | $383M |
HCMA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +360% | +26.4M shares |
| 3 years | -13% | -5.1M shares |
HCMA has 34M diluted shares, up 360% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q3 2023 | — |
| Q2 2023 | $258.5M |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
BLK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.0x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2024 | 0.2x | Very low |
| Q1 2024 | 0.3x | Very low |
| Q4 2023 | 0.1x | Very low |
BLK has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like BLK.
HCMA Net Leverage
BLK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.5 | Neutral |
| Stochastic | 79.0 | Neutral |
BLK's weekly RSI is 64 (neutral) and its Stochastic is 79 (neutral).
HCMA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.3 | Neutral |
| Stochastic | 86.7 | Overbought |
HCMA's weekly RSI is 64 (neutral) and its Stochastic is 87 (overbought).
BLK PE vs Financial Services Sector
| Metric | BLK | Sector median | Relative |
|---|---|---|---|
| PE | 28x | 13x | 113% above |
| PE % | 97 | 63 | 34 pts above |
BLK has the edge over HCMA on valuation relative to its sector.
HCMA PE vs Financial Services Sector
| Metric | HCMA | Sector median | Relative |
|---|---|---|---|
| PE | 63x | 13x | 384% above |
| PE % | 43 | 10 | 33 pts above |
HCMA is trading at 63x earnings, a 384% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
BLK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,128.0 | 7.9% above |
| 20 week MA | $1,108.9 | 9.7% above |
| 50 week MA | $1,071.6 | 14% above |
| 100 week MA | $1,051.1 | 16% above |
| 200 week MA | $914.1 | 33% above |
HCMA has stronger trend alignment. BLK is above 5 of 5 weekly averages versus HCMA above 3 of 3.
HCMA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.3 | 0.3% above |
| 20 week MA | $10.3 | 0.4% above |
| 50 week MA | $10.2 | 1.3% above |
HCMA is in an uptrend: it's above all three of its weekly moving averages, and 1.3% above its 50-week average.
BLK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $503.0 | $707.2 | +41% |
| 2021 | $707.2 | $913.9 | +29% |
| 2022 | $913.9 | $703.9 | -23% |
| 2023 | $703.9 | $811.8 | +15% |
| 2024 | $811.8 | $1,044.2 | +29% |
| 2025 | $1,044.2 | $1,088.1 | +4.2% |
| 2026 YTD | $1,088.1 | $1,216.6 | +12% |
BLK has the edge over HCMA on returns for 2026, with the stronger performance.
HCMA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $10.1 | $10.1 | -0.4% |
| 2026 YTD | $10.1 | $10.3 | +2.7% |
HCMA has finished every year since 2025 lower, and it's up 2.7% so far in 2026.